Kerendia (finerenone) is a prescription medication used to treat adults with chronic kidney disease (CKD) associated with type 2 diabetes. Kerendia is a mineralocorticoid receptor antagonist (MRA), which means it works by blocking the effects of aldosterone, a hormone that can damage the kidneys, heart, and blood vessels.